Profile picture

Doctor Hiroyoshi Yokoi

Fukuoka Sanno Hospital, Fukuoka (Japan)
Follow
Logo ESC

Contributor content

Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices from Japan Post-Market Surveillance Study
Presentation
Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices from Japan Post-Market Surveillance Study
Comparison of long DAPT versus short DAPT in Japanese PCI patients based on healthcare information database
Presentation
Comparison of long DAPT versus short DAPT in Japanese PCI patients based on healthcare information database
The Zilver PTX japanese post-market surveillance study of paclitaxel-eluting stents: 3 year results of the diabetic and in-stent restenosis subgroups
Presentation
The Zilver PTX japanese post-market surveillance study of paclitaxel-eluting stents: 3 year results of the diabetic and in-stent restenosis subgroups
Impact of pioglitazone on cardiovascular events in patients with type-II diabetes mellitus after drug-eluting stent implantation
Presentation
Impact of pioglitazone on cardiovascular events in patients with type-II diabetes mellitus after drug-eluting stent implantation
Zilver PTX post-market surveillance study of paclitaxel-eluting stents for treating femoropopliteal artery disease in Japan: 24-month results
Presentation
Zilver PTX post-market surveillance study of paclitaxel-eluting stents for treating femoropopliteal artery disease in Japan: 24-month results
Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices from Japan Post-Market Surveillance Study
Presentation
Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices from Japan Post-Market Surveillance Study

ESC 365 is supported by